SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Collegium Pharmaceutical, Inc. (COLL) News

Track canonical SquawkNews coverage tagged to COLL, Collegium Pharmaceutical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol COLL Asset equity Sector Markets 90 days 8 Last 22.79 Updated Sep 23, 2026, 11:09 AM UTC Open live news feed
L Collegium Pharmaceutical Price Target Announced at $50.00/Share by Oppenheimer Ratings actions from Benzinga NEWS | Sep 23, 2026, 11:09 AM UTC L Truist maintains Buy on Collegium Pharmaceutical; cuts price target to $49 Truist Securities maintained a Buy on Collegium Pharmaceutical and cut its price target to $49.00 per share from $58.00, per Benzinga/TradingView. EQUITY | Sep 09, 2026, 04:26 PM UTC L Collegium Pharmaceutical price target set at $45 by Leerink Leerink Partners announced a $45.00/share price target for Collegium Pharmaceutical. EQUITY | Sep 09, 2026, 03:26 PM UTC L Collegium management to participate in upcoming investor conferences Collegium Pharmaceutical, Inc. said management will participate in upcoming investor conferences, according to a company announcement. EQUITY | Sep 08, 2026, 12:07 PM UTC L COLL - Collegium to Participate in Upcoming Investor Conferences COLL - Collegium to Participate in Upcoming Investor Conferences EQUITY | Sep 08, 2026, 12:00 PM UTC M Collegium announces $50 million accelerated share repurchase program Collegium (COLL) announces a $50 million accelerated share repurchase program. EQUITY | Aug 13, 2026, 11:30 AM UTC L Collegium Pharmaceutical Lowers FY2026 Sales Guidance from $865.000M-$895.000M to $825.000M-$855.000M vs $872.278M Est Collegium Pharmaceutical (NASDAQ: COLL ) lowers FY2026 sales outlook from $865.000 million-$895.000 million to $825.000 million-$855.000 million vs $872.278 million estimate. EARNINGS | Aug 06, 2026, 11:31 AM UTC L COLL - Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress COLL - Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress EARNINGS | Aug 06, 2026, 11:30 AM UTC